$SKFG
Stark Focus Group, Inc.

2021 Q3 Form 10-Q Financial Statement

#000164033421001972 Filed on August 18, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2021 Q2 2020 Q2
Revenue $0.00 $13.27K $12.67K
YoY Change 4.77%
Cost Of Revenue $10.83K $10.30K
YoY Change 5.15%
Gross Profit $2.443K $2.369K
YoY Change 3.12%
Gross Profit Margin 18.41% 18.7%
Selling, General & Admin $11.05K $21.58K $20.39K
YoY Change 5.06% 5.84%
% of Gross Profit 883.42% 860.79%
Research & Development $0.00
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00
YoY Change
% of Gross Profit
Operating Expenses $11.05K $21.58K $20.39K
YoY Change 5.06% 5.84%
Operating Profit -$11.05K -$21.58K -$18.02K
YoY Change 5.06% 19.75%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$9.240K -$35.84K
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$10.15K -$21.13K -$18.02K
YoY Change 45.17% 17.22%
Net Earnings / Revenue -159.2% -142.28%
Basic Earnings Per Share
Diluted Earnings Per Share -$993.10 -$3.464K
COMMON SHARES
Basic Shares Outstanding 10.22M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q3 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $15.92K $3.550K
YoY Change
Cash & Equivalents $15.92K $3.552K $5.358K
Short-Term Investments
Other Short-Term Assets $0.00 $0.00
YoY Change
Inventory
Prepaid Expenses $0.00 $0.00
Receivables
Other Receivables
Total Short-Term Assets $15.92K $3.550K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets -$3.00 $2.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $15.92K $3.550K
Total Long-Term Assets -$3.00 $2.00
Total Assets $15.92K $3.552K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.770K $11.82K
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $83.80K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.770K $95.62K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $4.770K $95.62K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $4.765K $95.62K
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$145.4K -$136.1K
YoY Change
Common Stock $1.022K $1.022K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $11.15K -$92.07K
YoY Change
Total Liabilities & Shareholders Equity $15.92K $3.552K
YoY Change

Cashflow Statement

Concept 2021 Q3 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income -$10.15K -$21.13K -$18.02K
YoY Change 45.17% 17.22%
Depreciation, Depletion And Amortization $0.00
YoY Change
Cash From Operating Activities $96.17K -$28.89K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $1.280K
YoY Change
Cash From Investing Activities $1.280K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -83.80K 29.55K
YoY Change
NET CHANGE
Cash From Operating Activities 96.17K -28.89K
Cash From Investing Activities 1.280K
Cash From Financing Activities -83.80K 29.55K
Net Change In Cash 12.37K 660.0
YoY Change
FREE CASH FLOW
Cash From Operating Activities $96.17K -$28.89K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-18684 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-18023 USD
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10220830 shares
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3552 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3100 USD
CY2021Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
0 USD
CY2021Q2 us-gaap Assets
Assets
3552 USD
CY2021Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
11820 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
15822 USD
CY2021Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
83803 USD
CY2020Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
43082 USD
CY2021Q2 us-gaap Liabilities
Liabilities
95623 USD
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
1022 USD
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
43026 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-136119 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-92071 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3552 USD
CY2021Q2 us-gaap Revenues
Revenues
13271 USD
CY2020Q2 us-gaap Revenues
Revenues
12667 USD
us-gaap Revenues
Revenues
19631 USD
us-gaap Revenues
Revenues
18888 USD
us-gaap Revenues
Revenues
89983 USD
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
10828 USD
CY2020Q2 us-gaap Cost Of Revenue
CostOfRevenue
10298 USD
us-gaap Cost Of Revenue
CostOfRevenue
16061 USD
us-gaap Cost Of Revenue
CostOfRevenue
15578 USD
us-gaap Cost Of Revenue
CostOfRevenue
74399 USD
CY2021Q2 us-gaap Gross Profit
GrossProfit
2443 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
2369 USD
us-gaap Gross Profit
GrossProfit
3570 USD
us-gaap Gross Profit
GrossProfit
3310 USD
us-gaap Gross Profit
GrossProfit
15584 USD
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
21127 USD
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
20392 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
39837 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
51601 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
151702 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-36267 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-48291 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-136118 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-18684 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-18023 USD
CY2021Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2020 us-gaap Profit Loss
ProfitLoss
-91852 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-55804 USD
us-gaap Profit Loss
ProfitLoss
-36267 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-92071 USD
us-gaap Net Income Loss
NetIncomeLoss
-36267 USD
us-gaap Net Income Loss
NetIncomeLoss
-48291 USD
us-gaap Net Income Loss
NetIncomeLoss
-136118 USD
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2021Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
10220830 shares
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
10220830 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
10220830 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1022830 shares
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
36048 USD
us-gaap Net Income Loss
NetIncomeLoss
-48291 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
0 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
7522 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-4002 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
9970 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-40269 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-30799 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
40721 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
5837 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
40721 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5837 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
452 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-24962 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3100 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30320 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3552 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5358 USD
us-gaap Interest Paid Net
InterestPaidNet
0 USD
us-gaap Interest Paid Net
InterestPaidNet
0 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2021Q2 us-gaap Other Liabilities
OtherLiabilities
95623 USD
CY2021Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
83803 USD
CY2019Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8000000 shares
CY2019Q3 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
1 pure
CY2018Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
31 USD
CY2018Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
200000 shares
CY2019Q3 us-gaap Minority Interest Ownership Percentage By Parent
MinorityInterestOwnershipPercentageByParent
0.7827 pure
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3552 USD
CY2021Q2 us-gaap Cash
Cash
3552 USD
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Due to the limited level of operations, the Company has not had to make material assumptions or estimates other than the assumption that the Company is a going concern.</p>
CY2019Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8000000 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10220830 shares

Files In Submission

Name View Source Status
0001640334-21-001972-index-headers.html Edgar Link pending
0001640334-21-001972-index.html Edgar Link pending
0001640334-21-001972.txt Edgar Link pending
0001640334-21-001972-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
stark-20210630.xsd Edgar Link pending
stark-20210630_cal.xml Edgar Link unprocessable
stark-20210630_def.xml Edgar Link unprocessable
stark-20210630_lab.xml Edgar Link unprocessable
stark-20210630_pre.xml Edgar Link unprocessable
stark_10q.htm Edgar Link pending
stark_10q_htm.xml Edgar Link completed
stark_ex311.htm Edgar Link pending
stark_ex321.htm Edgar Link pending